Evidence map›Paper›PMID 23713831›Full record

ArticleJournal of proteome research2013

Rapid assessment of RNAi-mediated protein depletion by selected reaction monitoring mass spectrometry.

Veronika A Glukhova, Daniela M Tomazela, Geoffrey D Findlay, Raymond J Monnat, Michael J MacCoss

Abstract read
In one paragraph

Article in Journal of proteome research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. RNAi screening in Drosophila cells and in vivo.Methods (San Diego, Calif.) · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Veronika A GlukhovaDepartments of Genome Sciences and Pathology, University of Washington, Seattle, Washington 98195, USA.
Daniela M Tomazela
Geoffrey D Findlay
Raymond J Monnat
Michael J MacCoss

Funding

Tumor mutation signaturesP01CA077852 · NCI · UNIVERSITY OF WASHINGTON · PI MONNAT, RAYMOND J · 1999 to 2019
$26.0M
ZDS2P REGULATES SWE1P-DEPENDENT POLARIZED CELL GROWTH IN S CEREVISIAEP41RR011823 · NCRR · UNIVERSITY OF WASHINGTON · PI DAVIS, TRACY · 1996 to 2011
$24.7M
INTERDISCIPLINARY TRAINING IN GENOMIC SCIENCEST32HG000035 · NHGRI · UNIVERSITY OF WASHINGTON · PI Bruce Colston Trapnell · 1995 to 2026
$24.2M
TrainingP41GM103533 · NIGMS · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL · 2012 to 2021
$20.7M
Skyline Targeted Proteomics EnvironmentR01GM103551 · NIGMS · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL · 2012 to 2020
$3.4M
Analysis of Protein Dynamics in C. elegans by mLC/MS/MSR01DK069386 · NIDDK · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL · 2006 to 2013
$2.3M
Drosophila Seminal Fluid: Proteomic Discovery & Functional Variation AnalysesR01HD057974 · NICHD · UNIVERSITY OF WASHINGTON · PI SWANSON, WILLIE J · 2008 to 2012
$1.6M
NCI NIH HHS P01 CA077852NCI NIH HHS P01 CA77852NCRR NIH HHS P41 RR011823NHGRI NIH HHS T32 HG000035NHGRI NIH HHS T32 HG00035NICHD NIH HHS R01 HD057974NIDDK NIH HHS R01 DK069386NIGMS NIH HHS P41 GM103533NIGMS NIH HHS R01 GM103551
6 · The paper itself

Abstract

We describe the use of a targeted proteomics approach, selected reaction monitoring (SRM) mass spectrometry, to detect and assess RNAi-mediated depletion or "knockdown" of specific proteins from human cells and from Drosophila flies. This label-free approach does not require any specific reagents to confirm the depletion of RNAi target protein(s) in unfractionated cell or whole organism extracts. The protocol described here is general, can be developed rapidly, and can be multiplexed to detect and measure multiple proteins at once. Furthermore, the methodology can be extended to any tandem mass spectrometer, making it widely accessible. This methodology will be applicable to a wide range of basic science and clinical questions where RNAi-mediated protein depletion needs to be verified, or where differences in relative abundance of target proteins need to be rapidly assessed between samples.

Indexed as

RNA InterferenceAnimalsCell LineDrosophilaGene Knockdown TechniquesHumansPeptide FragmentsProteinsProteomicsTandem Mass SpectrometryPeptide FragmentsProteins

Identifiers

PMID23713831
PMCPMC3767422

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.